• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

敏感测序分析提示促甲状腺激素受体和鸟苷酸结合蛋白 G 亚单位α是热甲状腺结节中的唯一驱动突变。

Sensitive Sequencing Analysis Suggests Thyrotropin Receptor and Guanine Nucleotide-Binding Protein G Subunit Alpha as Sole Driver Mutations in Hot Thyroid Nodules.

机构信息

Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, Canada.

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada.

出版信息

Thyroid. 2020 Oct;30(10):1482-1489. doi: 10.1089/thy.2019.0648. Epub 2020 May 12.

DOI:10.1089/thy.2019.0648
PMID:32284013
Abstract

Constitutively activating mutations in the thyrotropin receptor () and the guanine nucleotide-binding protein G subunit alpha () are the primary cause of hot thyroid nodules (HTNs). The reported prevalence of and mutations in HTNs varies. Previous studies show mutations in 8-82% of HTNs and mutations in 8-75% of HTNs. With sensitive and comprehensive targeted next-generation sequencing (tNGS), we re-evaluated the prevalence of and mutations in HTNs. Samples from three previous studies found to be and mutation negative were selected and re-evaluated using high-resolution melting (HRM) PCR. Remaining mutation negative samples were further reanalyzed by tNGS with a sequencing depth between 3000 × and 10,000 × . Our tNGS panel covered the entire coding sequence along with mutation hot spots in . Sequencing reads were aligned to reference and variants were called using Torrent Suite software v5.8. In total, 154 of 182 previously mutation negative HTNs were positive for or mutations, resulting in an 85% prevalence of and mutations in HTNs, 79% and 6%, respectively. In a subset of 25 HTNs with multiple samples per nodule, and analyzed by tNGS at high sequencing depth, mutations were detected in 23 (92%) HTNs and 1 mutation was detected in 1 (4%) HTN, 96% mutation positive HTNs in this subset. Owing to the higher sensitivity of tNGS as compared with denaturing gradient gel electrophoresis and HRM-PCR, or mutations could be detected in 85% of HTNs. The detection of and mutations occurred in 96% of HTNs in a sample set with multiple samples per nodule analyzed by tNGS. Taken together with the fact that no other driver mutations could be identified by whole exome sequencing, our study strongly supports the hypothesis that and mutations are the main somatic mutations leading to HTNs.

摘要

促甲状腺激素受体 () 和鸟苷酸结合蛋白 G 亚单位 alpha () 的组成性激活突变是热甲状腺结节 (HTN) 的主要原因。HTN 中 和 突变的报道患病率有所不同。先前的研究显示,HTN 中 突变的发生率为 8-82%, 突变的发生率为 8-75%。通过敏感和全面的靶向下一代测序 (tNGS),我们重新评估了 HTN 中 和 突变的流行率。选择了来自之前三个研究的被发现为 和 突变阴性的样本,并使用高分辨率熔解 (HRM) PCR 对其进行重新评估。其余突变阴性的样本通过 tNGS 进一步重新分析,测序深度为 3000×至 10000×。我们的 tNGS 面板涵盖了整个 编码序列以及 中的突变热点。测序reads 与参考序列比对,并使用 Torrent Suite 软件 v5.8 调用变体。总共,在 182 个之前突变阴性的 HTN 中,有 154 个为 或 突变阳性,这导致 HTN 中 和 突变的患病率分别为 85%和 6%,分别为 79%和 6%。在 25 个 HTN 中有多个结节样本的亚组中,通过 tNGS 在高测序深度下进行分析,在 23 (92%)个 HTN 中检测到 突变,在 1 (4%)个 HTN 中检测到 1 个 突变,在该亚组中 96%的 HTN 为 突变阳性。与变性梯度凝胶电泳和 HRM-PCR 相比,由于 tNGS 的灵敏度更高,因此可以在 85%的 HTN 中检测到 或 突变。在通过 tNGS 对每个结节有多个样本进行分析的样本集中,在 96%的 HTN 中检测到 和 突变。再加上通过全外显子组测序无法识别其他驱动突变的事实,我们的研究强烈支持这样的假设,即 和 突变是导致 HTN 的主要体细胞突变。

相似文献

1
Sensitive Sequencing Analysis Suggests Thyrotropin Receptor and Guanine Nucleotide-Binding Protein G Subunit Alpha as Sole Driver Mutations in Hot Thyroid Nodules.敏感测序分析提示促甲状腺激素受体和鸟苷酸结合蛋白 G 亚单位α是热甲状腺结节中的唯一驱动突变。
Thyroid. 2020 Oct;30(10):1482-1489. doi: 10.1089/thy.2019.0648. Epub 2020 May 12.
2
Expression of G(alpha)(s) proteins and TSH receptor signalling in hyperfunctioning thyroid nodules with TSH receptor mutations.促甲状腺激素受体突变的高功能甲状腺结节中G(α)(s)蛋白的表达及促甲状腺激素受体信号传导
Eur J Endocrinol. 2002 Jul;147(1):109-16. doi: 10.1530/eje.0.1470109.
3
Prevalence of TSH receptor and Gsalpha mutations in 45 autonomously functioning thyroid nodules in Japan.日本45个自主功能性甲状腺结节中促甲状腺激素受体和Gsα突变的患病率
Endocr J. 2009;56(6):791-8. doi: 10.1507/endocrj.k09e-073. Epub 2009 Jun 24.
4
Detection of thyroid-stimulating hormone receptor and Gsalpha mutations: in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis.甲状腺刺激激素受体和Gsα突变的检测:通过变性梯度凝胶电泳检测75个毒性甲状腺结节。
J Mol Med (Berl). 2001;78(12):684-91. doi: 10.1007/s001090000170.
5
Similar prevalence of somatic TSH receptor and Gsalpha mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey.在土耳其不同碘供应的地理区域,毒性甲状腺结节中促甲状腺激素受体和Gsα亚基突变的发生率相似。
Eur J Endocrinol. 2006 Oct;155(4):535-45. doi: 10.1530/eje.1.02253.
6
A family with congenital hypothyroidism caused by a combination of loss-of-function mutations in the thyrotropin receptor and adenylate cyclase-stimulating G alpha-protein subunit genes.一个家族患有先天性甲状腺功能减退症,是由促甲状腺激素受体和腺苷酸环化酶刺激 G 蛋白亚基基因的功能丧失性突变共同引起的。
Thyroid. 2011 Feb;21(2):103-9. doi: 10.1089/thy.2010.0187. Epub 2010 Dec 27.
7
Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain.西班牙西北部缺碘地区加利西亚大量毒性甲状腺腺瘤中TSHR、GNAS、PRKAR1A和RAS基因突变的患病率
Eur J Endocrinol. 2008 Nov;159(5):623-31. doi: 10.1530/EJE-08-0313. Epub 2008 Aug 11.
8
High prevalence of TSHR/Gsα mutation-negative clonal hot thyroid nodules (HNs) in a Turkish cohort.土耳其队列中 TSHR/Gsα 突变阴性克隆性热甲状腺结节(HNs)的高患病率。
Horm Metab Res. 2011 Jul;43(8):562-8. doi: 10.1055/s-0031-1280829. Epub 2011 Jul 19.
9
Oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in the Japanese population.日本人群中自主功能性甲状腺结节促甲状腺激素受体的致癌突变。
Eur J Endocrinol. 2002 Sep;147(3):287-91. doi: 10.1530/eje.0.1470287.
10
Increased expression of G-protein-coupled receptor kinases 3 and 4 in hyperfunctioning thyroid nodules.功能亢进性甲状腺结节中G蛋白偶联受体激酶3和4的表达增加。
J Endocrinol. 2004 Jul;182(1):173-82. doi: 10.1677/joe.0.1820173.

引用本文的文献

1
Contract to kill: GNAS mutation.致命契约:GNAS 突变
Mol Cancer. 2025 Mar 7;24(1):70. doi: 10.1186/s12943-025-02247-4.
2
Autonomously functioning thyroid nodules present intermediate malignancy risk according to European Thyroid Imaging Reporting and Data System (EU-TIRADS) and yield indeterminate cytology results.自主功能性甲状腺结节根据欧洲甲状腺影像报告和数据系统(EU-TIRADS)具有中等恶性风险,且细胞学检查结果为不确定。
Eur Thyroid J. 2023 Dec 20;12(6). doi: 10.1530/ETJ-23-0135. Print 2023 Dec 1.
3
Activation of mitogen-activated protein kinase signaling and development of papillary thyroid carcinoma in thyroid-stimulating hormone receptor D633H knockin mice.
促甲状腺激素受体 D633H 敲入小鼠中海马状激酶信号的激活与甲状腺乳头状癌的发生。
Eur Thyroid J. 2023 Oct 3;12(6). doi: 10.1530/ETJ-23-0049. Print 2023 Dec 1.
4
A recurrent somatic missense mutation in GNAS gene identified in familial thyroid follicular cell carcinomas in German longhaired pointer dogs.在德国长毛指示猎犬的家族性甲状腺滤泡细胞癌中发现 GNAS 基因的频发种系错义突变。
BMC Genomics. 2022 Sep 23;23(1):669. doi: 10.1186/s12864-022-08885-y.
5
The Mysterious Universe of the TSH Receptor.促甲状腺激素受体的神秘宇宙。
Front Endocrinol (Lausanne). 2022 Jul 12;13:944715. doi: 10.3389/fendo.2022.944715. eCollection 2022.
6
Report of a family with three generations of undiagnosed familial nonautoimmune hyperthyroidism.三代未确诊的家族性非自身免疫性甲状腺功能亢进症家族报告。
Endocrinol Diabetes Metab Case Rep. 2021 Dec 1;2021. doi: 10.1530/EDM-21-0019.
7
Gs-Protein Kinase A (PKA) Pathway Signalopathies: The Emerging Genetic Landscape and Therapeutic Potential of Human Diseases Driven by Aberrant Gs-PKA Signaling.G 蛋白-蛋白激酶 A(PKA)信号通路信号病:异常 Gs-PKA 信号驱动的人类疾病的新兴遗传景观和治疗潜力。
Pharmacol Rev. 2021 Oct;73(4):155-197. doi: 10.1124/pharmrev.120.000269.